MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
DexCom EV - Enterprise Value 2011-2026 | DXCM
Annual EV - Enterprise Value DexCom
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.2 B | 29.5 B | 52.4 B | 44.7 B | 53.8 B | 36.5 B | 22.8 B | 12.8 B | 5.16 B | 6.59 B | 5.67 B | 4.47 B | 2.79 B | 1.06 B | 735 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 53.8 B | 735 M | 20.5 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B |  USA |
 |
Fulgent Genetics
FLGT
|
583 M | $ 18.53 | 1.59 % | $ 570 M | USA |
 |
Guardant Health
GH
|
15.2 B | $ 128.89 | -3.25 % | $ 16.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
16.5 B | $ 137.76 | 0.7 % | $ 10.8 B |  Irlanda |
 |
Agilent Technologies
A
|
45.8 B | $ 137.36 | 1.46 % | $ 41.8 B | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 1.7 | -5.56 % | $ 7.52 M | USA |
 |
Celcuity
CELC
|
5.57 B | $ 132.9 | 1.52 % | $ 6.21 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 8.52 | -23.86 % | $ 11.3 M | USA |
 |
Castle Biosciences
CSTL
|
463 M | $ 21.21 | -4.07 % | $ 615 M | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 22.88 | 0.79 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
15.3 B | $ 164.99 | 4.03 % | $ 26.2 B | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 99.99 | 0.37 % | $ 6.75 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 178.15 | 1.13 % | $ 24.3 B |  Schweiz |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 10.59 | 3.88 % | $ 1.36 B | USA |
 |
National Research Corporation
NRC
|
432 M | $ 19.8 | 0.71 % | $ 443 M | USA |
 |
Natera
NTRA
|
5.53 B | $ 221.23 | 3.41 % | $ 21.8 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 184.01 | 1.47 % | $ 9.12 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 452.2 | 0.91 % | $ 13 B | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 4.01 | -5.09 % | $ 371 M | USA |
 |
Personalis
PSNL
|
380 M | $ 11.43 | 4.1 % | $ 1.02 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 26.53 | 0.28 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.74 | 0.3 % | $ 281 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.39 | -1.74 % | $ 5.49 M | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 68.81 | -0.32 % | $ 4.12 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 262.23 | 0.08 % | $ 21.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 496.35 | 1.87 % | $ 187 B | USA |
 |
Trinity Biotech plc
TRIB
|
327 M | $ 0.71 | 1.24 % | $ 255 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.18 | -1.34 % | $ 1.99 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 195.62 | -0.3 % | $ 21.7 B | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |